Background: Recent investigations reported that osseointegration of titanium implants can be significantly reinforced with a nanostructure treated with anodic oxidation and heat treatment. This experimental study investigates the effect of bisphosphonates on the nanotubular implant surface in rats.
O ver the past several decades, titanium endosseous dental implants were used as an alternative functional and esthetic restoration in fully or partially edentulous patients. 1 The predictable success of endosseous dental implants is based on the primary stability in the placement of dental implants and the long-term rigid osseointegration formed between the host bone and implants. The characteristics of implant surface are an essential factor to consider when attempting to accelerate osseointegration.
Titanium has been used extensively in the field of dentistry and orthopedic surgery because of its excellent mechanical properties, higher degree of corrosion resistance, low specific weight, and bioinertness. The bioinertness of titanium results from the non-reactive titanium dioxide (TiO 2 ) layer, which is formed spontaneously on the surface of titanium in the body. 2 This oxide layer helps prevent the degradation of dental implants in the human body. However, a prolonged period of time is needed for osseointegration compared to bioactive materials. 3 The latest clinical trends of dental implants focus on methods to reduce the overall treatment period. For this reason, various surface-treatment methods to promote activity to the implant surface have been proposed. 4, 5 In recent years, it was reported that the formation of a titanium implant surface with a nanostructure could significantly reinforce the osseointegration. [6] [7] [8] [9] [10] [11] [12] An oxide layer of nanotube titania with an ordered array, larger surface area, and higher level of surface energy can be formed by an anodic oxidation treatment on pure titanium or titanium-alloy surfaces. [6] [7] [8] [9] [10] [11] [12] An anodic oxidation treatment can form an oxide film with a homogeneous thickness regardless of the surface shape of dental implants. The thickness and characteristics of the oxide layer can be adjusted by controlling processing factors, such as voltage, current density, and electrolyte compositions. 13 The surface of a nanostructure can induce the migration of osteoblasts [6] [7] [8] and mesenchymal stem cells [9] [10] [11] and promote cell differentiation and matrix synthesis, leading to accelerated osseointegration. Because materials, such as hydroxyapatite and collagen, that form on an implant surface during osseointegration have a nanosized structure, it is believed that a nanostructured surface would be more favorable for osseointegration. 12 The empty space of TiO 2 nanotubes can be used as a drug-delivery carrier (i.e., as an ideal drug-storage matrix that can locally deliver drugs over a long period after the implantation of dental implants). The local delivery of drugs in dental implants aims to release the drugs solely at the specific target with a relatively lower dose and minimize the systemic drug toxicity. 7, 14 The drug immobilization into a nanotube can be applied to various chemicals, drugs, and biomolecules with sizes ranging from small molecules to proteins, which can reduce the inflammation and promote the osteoblastic functions, thereby accelerating osseointegration. 14, 15 Bisphosphonates are drugs that are most commonly prescribed to patients with osteoporosis. Bisphosphonates, which are one of the pyrophosphate analogs, are composed of a P-C-P bond binding to hydroxyapatite (HA) crystals and two lateral chains. Of the lateral chains, R1 is associated with the binding force to bone mineral, and R2 plays a role in the antiosteoclastic efficacy. If osteoclasts can absorb bisphosphonates during bone resorption, the cytoskeleton within the osteoclasts would be destroyed, resulting in a loss of the boneresorption function, which would eventually lead to an apoptosis. Moreover, this phenomenon suppresses bone resorption strongly by suppressing the differentiation of osteoclasts and inhibiting the osteoclastic activity by promoting osteoblasts. 16 In vivo studies [17] [18] [19] of dental implants, whose surfaces were locally coated with bisphosphonates, revealed larger amounts of bone formation and a higher degree of bone-to-implant contact in the early stage than on non-coated implants. Therefore, the use of bisphosphonates on the surface of dental implants was believed to promote osteogenesis and to achieve faster osseointegration by suppressing the activity of osteoclasts on the interface between the bone tissue and dental implants.
Although positive effects of the nanotube structure or bisphosphonates on the osseointegration of titanium implants were suggested, [6] [7] [8] [9] [10] [11] [12] [17] [18] [19] there is a lack of up-to-date information regarding the effect of bisphosphonates on the osseointegration of nanotubular implants. Therefore, the purpose of this animal study was to investigate additional effects of bisphosphonates on the osseointegration of anodized and heat-treated (AH) titanium surfaces.
MATERIALS AND METHODS
Preparation of Samples With a Nanotube TiO 2 Layer, Heat, and Ibandronate Treatment Thirty-six dental implants (2-mm diameter · 4-mm length with five to six screw threads) were manufactured from commercially pure grade IV titanium** in a customizable manner. The dental implants were rinsed ultrasonically in a solution containing acetone and alcohol for 5 minutes each. All implants were stored in a dryer at 50°C for more than 24 hours before the anodic oxidation treatment. To form TiO 2 nanotubes, a titanium implant and platinum plate were connected to the cathode and anode of a direct-current power generator, † † respectively, and a pulse power of 20 V and 20 mA/cm 2 in 0.01-millisecond cycles was applied for 60 minutes. The electrolyte solutions were prepared by mixing glycerol with 20 weight % (wt%) H 2 O and 1 wt% NH 4 F. After the anodic oxidation treatment, the sample surface was rinsed ultrasonically for 1 minute. The samples were stored in a dryer at 50°C for 24 hours. Topographic characteristics of the TiO 2 nanotube structure were observed under field emission-scanning electron microscopy (FE-SEM). ‡ ‡ The structural stability of the nanotube TiO 2 layer and the removal of impurities were achieved by placing the samples in a furnace heated to 500°C at a heating rate of 10°C/minute for 2 hours. For bisphosphonate treatment, one group of the antiosteoporotic agents, ibandronate, was diluted in distilled water at a concentration of 1 mg/mL. Each implant was immersed in the diluted drugs in a 37°C incubator for 24 hours to allow for the absorption of the drug.
Experimental Design and Implantation Procedure
The study was conducted in compliance with the principles of the Helsinki Declaration of 1975, as revised in 2000. Ethical clearance of the study was approved by the Institutional Animal Care and Use Committee of the Chonbuk National University Laboratory Animal Center, Jeonju, South Korea.
For the experiment, both tibias of 18 male Wistar rats (12 weeks old and weighing 200 to 225 g) were used (total N = 36). Thirty-six dental implants were divided into the following three groups: 1) machineturned (MT) (untreated titanium; n = 12), 2) AH (n = 12), and 3) anodized and heat-and bisphosphonatetreated (AHB) (implants treated with ibandronate immobilization after the anodic oxidation and thermal treatment; n = 12).
The rats were allowed to acclimatize for 1 week before the experimental study. The implant placement surgery was performed under general anesthesia using intramuscular administration of 1:1 mixture of tiletamine and zolazepam (150 uL/200 g). § § The surgical site was shaved and disinfected with a betadine scrub. An incision of 1.0 cm in length was made, and the bone surface of the tibiae was surgically exposed by blunt dissection. Under a profuse saline-solution irrigation, bicortical implant beds were drilled at a rotary speed £1,500 rpm. In total, 36 screw-shaped titanium implants were placed using a self-tapping process in the medial region of the bilateral tibia diaphysis in the 18 rats until the screw thread was completely introduced into the bone cortex. Resorbable sutures ii were used to approximate the surgical wound. Postoperatively, amoxicillin (6 mg/kg) antibiotics and nabumetone (5 mg/kg) non-steroidal anti-inflammatory drugs were orally administered by dissolving them in the drinking water. Nine rats, each at 2 and 4 weeks after implantation, were sacrificed with an overdose of thiopental ¶ ¶ (six implants per time point, per group).
Removal Torque Analysis
The removal torque was measured at 2 and 4 weeks post-implantation. Implant sites in the rat tibia were surgically exposed via a sharp dissection to bone and clinically examined after the careful removal of overgrowing bone and soft tissues. An implant removal mount was securely fastened and engaged the external hex, which was connected to the torque gauge with the insertion device. Removal torque tests were performed on all implants (six implants per time point, per surface) in the tibia using a digital torque gauge. ## After stabilizing the legs, the torque was increased incrementally by slowly rotating the gauge counterclockwise. The manual torquing continued until a loosening of the implants was detected with the peak torque value recorded when a rupture occurred between the implant and bone. Peak torque measurements were recorded by a single examiner (T-SB) who was masked to the implant surface characteristics. Mean torque measurements were calculated for each group.
Analysis of Bone-Formation Markers by Western Blot
At 4 weeks, immediately after removal torque measurements, bone tissue was collected in the areas adjacent to the surface of the implants that were removed. The tissue sample (six implants per surface) was rinsed with saline, and the blood components were removed. The tissue sample was ground using a homogenizer after adding a protein lysis buffer (20 mM Tris-HCl [pH 7.5], 137 mM NaCl, 10% glycerol, 1% Triton X-100, 1 mM Na 3 VO 4 , 1 mM phenylmethylsulfonylfluoride, and 1· protease inhibitor cocktail). After centrifugation at 12,000 · g for 15 minutes, supernatants were used as cell extracts. Levels of type I collagen and osteocalcin expression, which were involved in the maturation and mineralization of osteocytes, were confirmed by western blotting with appropriate antibodies. Total proteins from the rat tibia were separated with 10% sodium dodecyl sulfate-polyacrylamide gel electrophoresis and transferred to a polyvinylidene difluoride membrane.*** Membranes were blocked with 5% non-fat skim milk (weight/volume) in Tris-buffered saline containing 0.5% Tween-20 (volume/volume) (TTBS) at room temperature for 1 hour and then incubated overnight at 4°C with rabbit anti-type I collagen † † † or antiosteocalcin ‡ ‡ ‡ antibodies diluted 1:1,000 in 5% non-fat skim milk in TTBS. A horseradish peroxidase-conjugated antirabbit antibody § § § was used as the secondary antibody (1:5,000 to 1:10,000 dilution in 5% non-fat skim milk in TTBS for a 1-hour incubation at room temperature), and the antigen-antibody complexes were visualized using a kit. iii Microcomputerized Tomography (mCT) Observation One day before sacrifice at 2 and 4 weeks, the experimental rats were anesthetized, and implant areas were scanned with a mCT scanner. ¶ ¶ ¶ The voltage and current of the x-ray tube were 100 kV and 100 mA, respectively, with 240 milliseconds of exposure time. X-ray projections were obtained at 0.6°intervals with a scanning angular rotation of 360°. The image pixel size was set for 18.104 mm. Among those microimages, we especially selected images in which a screw line could be observed with the cross-section following the long axis of the implant.
Statistical Analyses
The mean and SD of removal torque values and protein expression were calculated. Independent t tests were used to compute 1) P values for differences in removal torque values of each group between 2 and 4 weeks, and 2) differences in the expression of bone-formation markers (type I collagen and osteocalcin) between the MT group and other groups (AH and AHB groups). The Tukey test was used to compute P values for differences in removal torque values among the three groups (MT, AH, and AHB). P <0.05 was considered statistically significant. All statistical analyses were carried out with computer software. ### 
RESULTS
Surface Structure of the Nanotube TiO 2 Layer of Dental Implants Figure 1shows FE-SEM images of the implant surface after anodizing treatment. As shown in Figure 1C , the surface consisted of a dense structure of independent, self-organized nanotubes with mean diameters of 152.6 -16.2 nm and 80.3 -10.8 nm (Fig. 1C) . Cross-sectional lateral views of the layer were obtained and showed that the diameters of nanotubes increased from the superior to inferior direction with a mean length of 506.7 -25.0 nm (Fig. 1D) . The nanotubes that were sectioned longitudinally revealed the presence of multiple empty spaces (Fig. 1E) . Table 1 presents the removal torque measured at 2 and 4 weeks after placing the dental implants. The removal torque was higher at 4 weeks than at 2 weeks in all groups, with the highest values in the AHB group at both time points (Table 1 ). In addition, statistically significant differences were found among the MT and the other two groups at both time points, with the MT being lowest (P <0.05) (Fig. 2) .
Removal Torque Analysis

Analysis of Bone Formation Markers
At 4 weeks postimplantation, the degree of mineralization was evaluated based on the levels of type I collagen and osteocalcin expression by western blot analysis. Levels of type I collagen and osteocalcin expression were similar in the bone tissues from the MT and AH groups. In contrast, there were significantly higher levels of type I collagen and osteocalcin expression in the bone tissue from the AHB group compared to other groups. Especially when compared with the MT group (100%) the collagen expression level of the AHB group was about two times higher (220.85% -71.09%) and the osteocalcin expression was about 3.6 times higher (363.04% -100.21%) than the MT group.
mCT Observation Figure 4 shows mCT images of implants placed in rat tibiae at 2 and 4 weeks after implantation. In the MT group, only the outer area of threads was radiopaque, with the inner area of threads being radiolucent on the images. The AH group also exhibited a similar finding. However, it was remarkable to see the AHB group displaying radiopacity on the outer and inner areas of threads. This implied that the intimate contacts between the implant and surrounding bone in the AHB group were the result of more bone deposition on the implant surface. This feature was more remarkable at 4 weeks than at 2 weeks, and the overall bone density also increased at 4 weeks.
DISCUSSION
For the present study, the test titanium implants underwent anodic oxidation to form a nanotube, followed by a thermal treatment. Subsequently, ibandronate, one of the bisphosphonates, was penetrated into the nanotube structure. The results of this study revealed that the AHB implant group showed excellent biocompatibility and osseointegration that were superior to the MT and AH groups. This superiority was well demonstrated by the highest values of removal torque, protein expression, and analyses.
The removal torque analysis at 2 and 4 weeks revealed the highest values found in the AHB group as shown in Table 1 and Figure 2 . In addition, in all groups, the removal torque was relatively higher at 4 weeks than at 2 weeks, with statistically significant differences found in the MT and AHB groups. These outcomes correspond well with results of other studies 20, 21 in which bisphosphonate-treated titanium implants displayed a higher mechanical fixation than uncoated titanium implants. However, the experimental method used in the previous studies was different from our method. Although, in the present study, bisphosphonate treatment was made through nanotubes on the implant surface, the other studies used bisphosphonate treatment on the surface of hydoxyapatite-coated titanium implants. Furthermore, the results showed that the AH and AHB groups had significantly higher values of removal torque than did the MT group (Fig. 2) . This result showed that the rough surface with a TiO 2 -nanotube layer might have contributed to the increased values of removal torque in the AH and AHB groups. The most-increased removal torque values in the AHB group indicated a higher friction force between the implant and surrounding bone, suggesting that a higher degree of osseointegration existed in this type of implant.
mCT images taken at 2 and 4 weeks after placing dental implants showed that the areas adjacent to the implant screws were clearer and denser in the AHB group than in the MT and AH groups (Fig. 4) . This result indicated that the degree of bone contact with the implants was relatively higher in the AHB group, and more bone was formed in the areas adjacent to the implant. The mCT results and increased removal torque suggested that the surface treated with bisphosphonates ### SPSS 12.0 for Windows, IBM, Chicago, IL.
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as well as the surface with a nanotube structure might have induced an increase in bone formation, which could have affected the physiochemical interactions with adjacent bones. The increased expression of bone formation markers (Fig. 3) indirectly reflect the increased bone formation in the AHB group. The degree of type I collagen and osteocalcin expression was highest in the AHB group and with statistical significance. Type I collagen is one of the most common collagenous bone proteins that accounts for >90% of the bone matrix, which reflects the bone formation. Osteocalcin is an osteogenic marker that reflects the functions of osteoblasts in association with the minerals contained in the bone matrix. Hence, the highest levels of type I collagen and osteocalcin expression in the AHB group indicated that the activities of bone formation were the greatest in the bisphosphonate-treated nanotubular implants.
Positive effects of bisphosphonate treatment on the implant surface in promoting osseointegration were demonstrated in the literature. [17] [18] [19] 22 Meraw et al. 17, 18 examined the effects of alendronate on bone regeneration after an alendronate treatment on the surface of dental implants in an animal experimental model using dogs. They 17, 18 reported that the use of alendronate increased the initial bone formation and bone-to-implant contact in the areas adjacent to the implant. 17, 18 Zuffetti et al. 19 performed a histopathologic examination on bisphosphonate-treated implants 2 months post-implantation in humans and showed that the bone density and degree of bone-to-implant contact were higher in bisphosphonate-treated implants than in control implants. Furthermore, in a recent report, 22 bisphosphonate-treated implants were placed in the maxilla of five patients using a two-stage surgical procedure, and the implant stability quotient (ISQ) was measured at stage-I implant surgery and after 6 months. The results revealed that the largest improvements in the ISQ level of all implants were found for bisphosphonate-treated implants.
There is still some controversy regarding the mechanisms by which TiO 2 nanotubes are formed by anodic oxidation. The formation of nanotubes has been suggested to originate from the electrochemical growth of an oxide layer and the dissolution of metal oxide by fluoride ions. 23 In this study, the anodic oxidation was performed at 20 V and 20 mA/cm 2 in a glycerol solution containing 1 wt% NH 4 F and 20 wt% H 2 O. Accordingly, in the early stage, an oxide layer was formed over the surface because of the electrochemical oxidation. Subsequently, the oxide layer that formed in the early stage dissolved, followed by the formation of a self-organized TiO 2 nanotube layer after 1 hour of anodic oxidation. The empty space within the TiO 2 nanotube can be used as a drug-delivery carrier that can reduce the inflammation or accelerate osseointegration by promoting osteoblastic functions as well as by suppressing osteoclast activities. According to Yao and Webster, 14 penicillin loaded into the anodized titanium with a nanotube structure using a coprecipitation method in vitro was released over a 3-week period via first-order kinetics. Compared to the untreated or anodized titanium, the level of bone-cell adhesion was further increased. 14 In addition, according to Bae et al., 15 after loading the immobilized recombinant human bone morphogenetic protein 2 in vitro, the drugs were released gradually from the anodized titanium with a nanotube structure over a 3-week period. The activity of osteoblasts was relatively higher than that observed on the nonanodized titanium samples. 15 Our previous in vitro study on the release mechanism of ibandronate also revealed that the drug deposition and release activity were considerably improved with the nanotube structure (unpublished data).
In the present study, the controlled release of bisphosphonates might have continuously promoted the osseointegration of the nanotube implants during the healing period as demonstrated by the higher mean removal torque values in the AHB group than in the MT and AH groups.
Bisphosphonates are known to have a strong affinity to calcium and HA, which have a great impact on the bone metabolism by binding to the bone tissue. Currently, bisphosphonates are used to treat bone metabolic diseases, such as osteoporosis, Paget disease, multiple myeloma, and solid tumors associated with the bone metabolism. Reddy et al. 24 and Weinreb et al. 25 investigated the effects of bisphosphonates in animal models in which alveolar bone resorption was induced by experimental periodontitis. In the studies, 24, 25 it was shown that the systemic administration of alendronate showed a positive effect in Comparison of removal torque values among groups. *Statistically significant differences between the MT group and AH and AHB groups at 2 and 4 weeks (P <0.05; Tukey test). Histogram representing the levels of osteocalcin protein relative to that of the MT group. *Significantly higher level of type I collagen and osteocalcin expression in the bone tissue from the AHB group (P <0.05; independent t test).
reducing bone loss and increasing bone density. In other studies, 26, 27 dental implants were placed with or without a subcutaneous injection of alendronate in rats in which osteoporosis was induced by a bilateral ovariectomy. Removal torque values were significantly higher in the alendronate-treated group than in the other group that had undergone an ovariectomy only. The results of the studies 26, 27 suggested that systemic bisphosphonate administration might have improved the osseointegration of titanium implants placed in osteoporotic bone.
The systemic use of bisphosphonates has been cautioned because of some side effects, such as esophagitis, gastric ulcers, and osteonecrosis of the jaw (ONJ). [28] [29] [30] [31] In particular, ONJ may occur after a tooth extraction (or a treatment involving the dento-alveolar structure) in a patient who received a systemic administration of bisphosphonates. ONJ was first reported in 2003, 28 but the precise mechanism is unclear. According to Marx et al., 29 the occurrence of ONJ might be associated with an impairment of bone remodeling and regeneration and the insufficient blood supply in patients given bisphosphonates. More than 90% of reported cases were described in cancer patients who received an intravenous injection of bisphosphonate at higher doses. In these cases, the incidence was associated with the dose and treatment period. According to the latest research, 30, 31 only the use of a high dose of bisphosphonates was associated with the occurrence of ONJ in cancer patients. However, it was reported that the use of a lower bisphosphonate dose might have almost no relationship with the occurrence of ONJ in patients with osteoporosis. 30, 31 Therefore, it was suggested that the local use of bisphosphonates in dental implants may not be contraindicated. 30, 31 CONCLUSIONS In this in vivo, non-human experiment, the removal torque, bone density, and degree of bone-formation marker expression increased after an ibandronate treatment of an anodized implant with a nanotube structure. These results suggested that this surface treatment increased the biocompatibility of the implant surface, promoted the formation of the adjacent bone, and accelerated osseointegration. Additional studies, including long-term clinical trials and histologic and histomorphometric analyses, are required to confirm the results of the present study. mCT scan images at 2 (A) and 4 (B) weeks. *The bottom area of threads of the MT implant was radiolucent, which meant the absence of bone.
† The bottom area of threads of the AHB implant was radiopaque indicating the presence of bone.
